Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells

BACKGROUND: The use of glucose as the only osmotic agent in peritoneal dialysis (PD) solutions (PDSs) is believed to exert local (peritoneal) and systemic detrimental actions, particularly in diabetic PD patients. To improve peritoneal biocompatibility, we have developed more biocompatible PDSs cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonomini, Mario, Di Silvestre, Sara, Di Tomo, Pamela, Di Pietro, Natalia, Mandatori, Domitilla, Di Liberato, Lorenzo, Sirolli, Vittorio, Chiarelli, Francesco, Indiveri, Cesare, Pandolfi, Assunta, Arduini, Arduino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135076/
https://www.ncbi.nlm.nih.gov/pubmed/27932866
http://dx.doi.org/10.2147/DDDT.S117078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135076/
https://www.ncbi.nlm.nih.gov/pubmed/27932866
http://dx.doi.org/10.2147/DDDT.S117078

Ejemplares similares